Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05650086 · ClinicalTrials.gov registry record
Novel Thermal Imaging Technique for Breast Screening
A clinical trial, sponsored by University of Arizona.
- Terminated
- Registry status
- 115
- Enrollment target
NCT05650086: Clinical Trial study, sponsored by University of Arizona.
NCT05650086 is a clinical trial that was terminated before completion, run by University of Arizona. The registered enrollment target is 115 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05650086 was terminated before completion, sponsored by University of Arizona.
- TERMINATED
- Registry status
- 115 participants
- Enrollment target
Study Summary
This trial is to study a new breast imaging tool called Thermalytix™. ThermalytixTM is a new radiation-free, automated breast cancer screening technique that uses Artificial Intelligence (AI) over thermal images. Thermal images are heat signatures in our body. This new technique will capture heat signatures in the breast and analyze those images with AI software. This study will evaluate the performance of ThermalytixTM breast imaging against standard imaging modalities, such as mammography and ultrasound.
Primary Outcome
Determine sensitivity and specificity of ThermalytixTM in detecting breast cancer in patients scheduled to undergo breast biopsy (Cohort 1). The sensitivity and specificity will be estimated using 95% exact binomial confidence intervals. The required sample size was determined based on the target sensitivity and specificity, and the resulting confidence intervals.
Interventions
- DEVICE Thermalytix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 115 participants |
| Start Date | 2022-11-15 |
| Est. Completion | 2023-06-30 |
Why NCT05650086 stopped before completion
NCT05650086 is an observational study that tracks outcomes without assigning an intervention. The registered 115 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Thermalytix is the first listed.
NCT05650086 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05650086 about?
NCT05650086 is a clinical study titled "Novel Thermal Imaging Technique for Breast Screening". This trial is to study a new breast imaging tool called Thermalytix™. ThermalytixTM is a new radiation-free, automated breast cancer screening technique that uses Artificial Intelligence (AI) over thermal images. Thermal images are heat signatures in our body. This new technique will capture heat si...
What is the current status of trial NCT05650086?
This trial is currently terminated. The enrollment target is 115 participants. The study started on 2022-11-15. Estimated completion is 2023-06-30.
What interventions are being tested in trial NCT05650086?
The interventions under investigation include: Thermalytix (DEVICE).
Who is sponsoring clinical trial NCT05650086?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02346929 · 115 participants · NA
Hematoma Block for Distal Radius Fracture
- NCT03394365 · 115 participants · Phase 3
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
- NCT03907475 · 115 participants · Phase 2
Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial
- NCT05086692 · 115 participants · Phase 1
A Beta-only IL-2 ImmunoTherapY Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI